SPAG9 expression was also bound up with circulating anti-SPAG9 antibodies, indicating that SPAG9 could be a promising noninvasive serum biomarker for early diagnosis and cancer management [22, 23, 27]. This evidence concerns the gene SPAG9 and cancer.